Connect Education Workshop Details
Help
Progress in the Treatment of Metastatic Breast Cancer
- Overview of Metastatic Breast Cancer
- Current Standard of Care
- New Treatment Approaches
- The Role of Clinical Trials
- How Clinical Research Affects Your Care
- Symptom and Pain Management
- Doctor-Patient Communication
- Questions for Our Panel of Experts
Hope S. Rugo, MD Clinical Professor of Medicine, Director, Breast Oncology Clinical Trials Program, UCSF Comprehensive Cancer Center |
|
Erica L. Mayer, MD, MPH Staff Physician, Breast Oncology Center , Dana-Farber Cancer Institute, Instructor in Medicine, Harvard Medical School |
|
Lidia Schapira, MD Assistant Professor of Medicine, Harvard Medical School. Staff Oncologist, Gillette Center for Breast Oncology, Massachusetts General Hospital |
|
Patricia Spicer, MSW Breast Cancer Program Coordinator, CancerCare |
|
AdvancedBC.org, African American Breast Cancer Alliance, American Cancer Society, American Pain Foundation, American Society of Clinical Oncology, Association of Clinicians for the Underserved, Association of Oncology Social Work, Black Women's Health Imperative, The Bone and Cancer Foundation, Breast Cancer Alliance, Breast Cancer Network of Strength, The Breast Cancer Research Foundation, Cancer Patient Education Network, Cancer Support Community, Education Network to Advance Cancer Clinical Trials, Intercultural Cancer Council, Joe's House, Latinas Contra Cancer, Linda Creed Breast Cancer Foundation, Living Beyond Breast Cancer, Men Against Breast Cancer, Metastatic Breast Cancer Network, Multinational Association of Supportive Care in Cancer, National Black Leadership Initiative on Cancer, National Coalition for Cancer Survivorship, National Family Caregivers Association, Redes en Acción: The National Latino Cancer Research Network, Research Advocacy Network, The Sister Study, Tigerlily Foundation, Triple Negative Breast Cancer Foundation, Vital Options International & The Group Room, The Witness Project, Young Survival Coalition
a charitable contribution from Bristol-Myers Squibb.
June 18, 2010
